7Tubaro A, Carter S, Hind A, et al. A prospective study of the safety and efficacy of suprapubic transvesi- cai prostatectomy in Patients with benign prostatic hyperplasia. J Urol, 2001,166:172-176.
8Blaivas JG.Obstructive uropathy in the male[J].Urol Clin North Am,1996,23(3):373-384.
9Hald T.Review of current treatment of benign prostate hyperplasia[J].Eur Urol,1994,25 (Suppl 1):15-19.
3Wein AJ,Kavoussi LR,Novick AC. Campbell-Walsh urology[M].Amsterdam:Elsevier Science Health Science div,2007.2803-2844.
4Chung DE,Kaplan SA. Current role for combination therapy in male LUTS[J].Archivos Espanoles de Urologia,2010,(05):323-332.
5Greco KA,McVary KT. The role of combination medical therapy in benign prostatic hyperplasia[J].International Journal of Impotence Research,2008,(03):33-43.
6Mayer EK,Kroeze SG,Chopra S. Examining the ′gold Standard′:a comparative critical analysis of three consecutive decades of monopolar transurethral resection of the prostate(TURP) outcomes[J].British Journal of Urology International,2012,(11):1595-1601.
7Clarke JC,Clarke H Jr. Combination 5-alpha-reductase inhibitors and alpha-blockers for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia[J].Current Urology Reports,2008,(04):291-294.
8AUA Practice Guideline Committee. AUA guideline on management of benign prostatic hyperplasia[S].USA:UA Practice Guideline Committee,2011.16-22.
9Krambeck AE,Jacobson DJ,McGree ME. Effectiveness of medical and surgical therapies for lower urinary tract symptoms in the community setting[J].British Journal of Urology International,2012,(09):1332-1337.
